✦ LIBER ✦

Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX

✍ Scribed by Alan S Coates, Ewan KA Millar, Sandra A O’Toole, Timothy J Molloy, Giuseppe Viale, Aron Goldhirsch, Meredith M Regan, Richard D Gelber, Zhuoxin Sun, Monica Castiglione-Gertsch, Barry Gusterson, Elizabeth A Musgrove, Robert L Sutherland

Book ID: 118726976
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 314 KB
Volume: 14
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr3348

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

325 PUBLICATION Prognostic relevance of

325 PUBLICATION Prognostic relevance of HER2 expression and gene amplification in estrogen receptor-positive lymph-node negative breast cancer patients

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Patterns of Recurrence and Outcome Accor

Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node-Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

✍ Metzger-Filho, O.; Sun, Z.; Viale, G.; Price, K. N.; Crivellari, D.; Snyder, R. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 181 KB

Association Between the 21-Gene Recurren

Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

✍ Mamounas, E. P.; Tang, G.; Fisher, B.; Paik, S.; Shak, S.; Costantino, J. P.; Wa 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 256 KB

Heterogeneic expression of estrogen rece

Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome

✍ Chikage Iguchi; Yoshinori Nio; Masayuki Itakura 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB 👁 2 views

762 Prognostic and Predictive Value of T

762 Prognostic and Predictive Value of TP53 Mutations in Node-positive Breast Cancer Patients Treated with Anthracycline-or Anthracycline/taxane Based Adjuvant Therapy – Results From the BIG 02-98 Phase III Trial

✍ M. Olivier; L. Fernández-Cuesta; C. Oakman; E. Quinaux; M.S. Dolci; P.A. Francis 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Decreased immunoreactivity for p27 prote

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status : Results from International Breast Cancer Study Group Trial V

✍ Vito J. Spataro; Heather Litman; Giuseppe Viale; Fausto Maffini; Michele Masullo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin‐dependent kinase inhibitor p27(Kip1) in patients with early‐stage breast carcinoma and to investigate its relation with clinicopathologic features and other m